Dr. Reddy’s CDMO arm Aurigene inks long-term manufacturing pact with global pharma major
The initial portfolio comprises more than 20 products across sterile injectables, biologics and topical formulations, which will be manufactured at Aurigene’s facilities in India.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.thehindu.com — the content belongs to The Hindu.
